Headache Clinical Trial
Official title:
Equity in Diagnostic Imaging Trial (EDIT)
This study will 1) Develop two interventions: a) an audit-feedback email intervention that provides clinicians with data on CT scan ordering practices by patient race; and b) a clinical decision support (CDS) message in the electronic medical record headache template; and 2) Compare the effectiveness of these 2 interventions in eliminating a previously observed Black-White disparity in CT scanning rates to rule out subarachnoid hemorrhage (SAH).
Investigators at our institution (Hwang & Richardson)* documented a racial disparity in the
use of CT scans to diagnose subarachnoid hemorrhage, (SAH) a life-threatening form of
stroke. Subsequent analyses found a similar finding in NHAMCS, a national ED Visit
database*. The investigators will compare the effectiveness of 1) an audit-feedback
intervention that provides data on race-specific CT rates and 2) a clinical decision support
(CDS) message in the electronic "headache" charting template in eliminating the previously
observed Black-White disparity in CT rates to rule out SAH.
Study Setting: The adult section of the Mount Sinai Emergency Department, an urban academic
department with an annual volume of over 70,000 adult visits and a patient population
representing a diverse cross-section of race and socioeconomic groups. The adult patients
are cared for by a staff that includes: attending physicians, physician assistants,
emergency medicine resident physicians, and rotating resident physicians from other
specialties. The department has a dedicated CT scanner that is readily available around the
clock. Epic Production is used for all physician and nurse documentation and for all order
entry (including CT scans).
Over a 24-month period the investigators will compare the intervention and control groups'
rates of testing for SAH across races, controlling for patient acuity, age and
co-morbidities. Because the close working relationships among the attending and resident
physicians in our department may lead to knowledge diffusion, the intervention may change
the behavior of the control group as well as the intervention group, thus leading to an
underestimation of the intervention effect as measured by the between- groups difference.
The investigators will use a time series design to allow us to evaluate this effect. 10
months after the implementation of the first intervention, the clinical decision support
message will be implemented. The impact of each intervention will be evaluated using a
repeated measures design using a mixed linear model.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03472872 -
A Comparative Efficacy Trial of IV Acetaminophen Versus IV Ketorolac for Emergency Department Treatment of Generalized Headache
|
Phase 4 | |
| Withdrawn |
NCT05410366 -
Safe Harbors in Emergency Medicine, Specific Aim 3
|
||
| Withdrawn |
NCT02866084 -
Neuromodulation Treatment of Vestibular Migraines
|
N/A | |
| Active, not recruiting |
NCT03537573 -
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
|
N/A | |
| Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
| Not yet recruiting |
NCT04352218 -
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
|
Phase 2 | |
| Completed |
NCT02734992 -
Acceptance and Commitment Therapy vs Medical Treatment as Usual Wait-list Control for Primary Headache Sufferers
|
N/A | |
| Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
| Completed |
NCT01327118 -
Prostaglandin F2alpha in a Human Headache Model
|
N/A | |
| Not yet recruiting |
NCT00969995 -
Identification of Inflammatory Markers in Migraine Patients
|
N/A | |
| Not yet recruiting |
NCT00752921 -
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
|
Phase 4 | |
| Terminated |
NCT00291395 -
PGI2 Induced Headache and Cerebral Haemodynamics in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00212810 -
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
|
Phase 4 | |
| Completed |
NCT00263094 -
An End to the Yom Kippur (and Ramadan) Headache
|
N/A | |
| Completed |
NCT00135122 -
Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache
|
Phase 3 | |
| Completed |
NCT02475005 -
An Intervention to Improve Adolescent Headache Self-management
|
N/A | |
| Completed |
NCT03163901 -
The Effect of OMT on Functional Outcomes and Anti-inflammatory Biomarkers in Mild to Moderate Traumatic Brain Injury
|
N/A | |
| Completed |
NCT01664585 -
Exercise Training With Physically Active Lifestyle to Reduce Headache and Quality of Life
|
N/A | |
| Completed |
NCT04632420 -
Evaluation of Headache and Childbirth in a Chronic Pain Population
|
||
| Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|